Revas is a brand family of Alembic Pharmaceuticals Ltd., sold in Nepal. The NepalDoc catalog lists 5 Revas products across 3 medicine lines: Losartan Potassium, Amlodipine + Losartan, Hydrochlorothiazide + Losartan Potassium.
Losartan potassium tablets are an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure in adults and children greater than 6 years old. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions., Reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy.
From the U.S. FDA-approved label for Losartan Potassium. Full label: DailyMed.
Losartan potassium tablets are an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure in adults and children greater than 6 years old. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions., Reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy. There is evidence that this benefit does not apply to Black patients., Treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria in patients with type 2 diabetes and a history of hypertension. 1.1 Hypertension Losartan potassium tablets are indicated for the treatment of hypertension in adults and pediatric patients 6 years of age and older, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and nonfatal cardiovascular (CV) events, primarily strokes and myocardial infarction. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including losartan.
From the U.S. FDA-approved label for Losartan Potassium. Full label: DailyMed.
Hypertension, Usual adult dose: 50 mg once daily., Usual pediatric starting dose: 0.7 mg per kg once daily (up to 50 mg). Hypertensive Patients with Left Ventricular Hypertrophy, Usual starting dose: 50 mg once daily., Add hydrochlorothiazide 12.5 mg and/or increase losartan potassium to 100 mg followed by an increase to hydrochlorothiazide 25 mg if further blood pressure response is needed. Nephropathy in Type 2 Diabetic Patients, Usual dose: 50 mg once daily., Increase dose to 100 mg once daily if further blood pressure response is needed.
Directions from the U.S. FDA-approved label for Losartan Potassium — your doctor or pharmacist may advise differently.
Losartan potassium is contraindicated: In patients who are hypersensitive to any component of this product., For coadministration with aliskiren in patients with diabetes., Hypersensitivity to any component., Coadministration with aliskiren in patients with diabetes.
Excerpt from the U.S. FDA-approved label for Losartan Potassium. Talk to a pharmacist or doctor before use.
Hypotension: Correct volume or salt depletion prior to administration of losartan potassium., Monitor renal function and potassium in susceptible patients. 5.1 Fetal Toxicity Losartan potassium can cause fetal harm when administered to a pregnant woman. Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death. Resulting oligohydramnios can be associated with fetal lung hypoplasia and skeletal deformations.
Warnings and precautions excerpt from the U.S. FDA-approved label for Losartan Potassium — not a complete list. Talk to a pharmacist or doctor before use.
Most common adverse reactions (incidence ≥2% and greater than placebo) are: dizziness, upper respiratory infection, nasal congestion, and back pain. To report SUSPECTED ADVERSE REACTIONS, contact Zydus Pharmaceuticals (USA) Inc. at 1-877-993-8779 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Excerpt from the U.S. FDA-approved label for Losartan Potassium — not a complete list. Talk to a pharmacist or doctor about side effects.
98 brands · 43 makers in the NepalDoc catalog — see the full Losartan Potassium guide →
Storage: Store at 20°C to 25°C (68°F to 77°F). Protect from light.
Storage information from the U.S. FDA-approved label for Losartan Potassium.
What is Revas 25?
Revas 25mg Tablet is a Losartan Potassium medicine made by Alembic Pharmaceuticals Ltd. It comes as 25mg Tablet.
What is Revas 25 used for?
According to its FDA label, Losartan Potassium is used for treatment of hypertension, to lower blood pressure in adults and children greater than 6 years old.
What is the generic name of Revas 25?
The generic name of Revas 25 is Losartan Potassium.
Which brands of Losartan Potassium are available in Nepal?
98 brands of Losartan Potassium are listed in the NepalDoc catalog, from 43 makers — including A Losart 25mg Tablet, A Losart 50mg Tablet, Alsartan 25mg Tablet, Alsartan 50mg Tablet, Alsrten 50mg Tablet, Angitan 25mg Tablet.
What are the side effects of Losartan Potassium?
Most common adverse reactions (incidence ≥2% and greater than placebo) are: dizziness, upper respiratory infection, nasal congestion, and back pain. To report SUSPECTED ADVERSE REACTIONS, contact Zydus Pharmaceuticals (USA) Inc.
What is the price of Revas 25 in Nepal?
NepalDoc does not list medicine prices. Prices are set by individual pharmacies in Nepal and change over time — this page confirms the brand sold in Nepal, its generic name, maker, strength and pack details so you can check the price at your pharmacy with confidence.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
Every NepalDoc section, one tap away.